🇺🇸 FDA
Patent

US 6231852

Method for reducing BCL-2 expressing cells resistance to death

expired A61KA61K31/05A61K31/06

Quick answer

US patent 6231852 (Method for reducing BCL-2 expressing cells resistance to death) held by The Regents of the University of California expires Mon May 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 15 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/05, A61K31/06, A61K31/085, A61K31/16